Myron Kaplan, Director at CorMedix Inc. (CRMD), bought 15,000 shares at $4.08 ($61K) on 2020-08-13, disclosed to the SEC on 2020-08-17.
Open-market purchase of $61k CRMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CRMD | BUY | 2022-05-18 | $19K | — | Filing → |
| CRMD | BUY | 2021-11-19 | $51K | — | Filing → |
| CRMD | BUY | 2021-05-19 | $90K | — | Filing → |